$1.00
-0.03-3.10%
At close: Sep 18, 6:11 PM EDT
$0.969000
-0.03-3.10%
After Hours: 6:11 PM EDT
15 minutes delayed
Comments
Loading...
Sonnet BioTherapeutics (NASDAQ:SONN) Stock, Earnings Estimates, EPS, And Revenue
Sonnet BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Dec 12
EPS Estimate
$-0.630
Quarterly Revenue Estimate
$30K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$55.9K
Analyze the earnings history of Sonnet BioTherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Sonnet BioTherapeutics (SONN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-14 | $-0.70 | $-0.76 | 7.89 % |
| Mar 2024 | 2024-05-14 | $0.07 | $0.13 | -46.2 % |
| Dec 2023 | 2024-02-14 | $-0.31 | $-0.90 | 65.6 % |
| Sep 2023 | 2023-12-14 | $-0.78 | $-0.90 | 13.3 % |
Sonnet BioTherapeutics (SONN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-14 | $0 | $30.00K | -100.0 % |
| Mar 2024 | 2024-05-14 | $0 | $10.00K | -100.0 % |
| Dec 2023 | 2024-02-14 | $18.63K | $20.00K | -6.87 % |
| Sep 2023 | 2023-12-14 | $37.26K | $20.00K | 86.3 % |
FAQ
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics (SONN) is scheduled to report earnings on December 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Sonnet BioTherapeutics (NASDAQ:SONN)?
The Actual EPS was $-0.70, which beat the estimate of $-0.76.
What were Sonnet BioTherapeutics’s (NASDAQ:SONN) revenues?
The Actual Revenue was $0K, which missed the estimate of $30K.
Browse earnings estimates, EPS, and revenue on all stocks.